A CoA is the single most important document in a peptide transaction — and the most frequently forged. Here is how to read one like a forensic analyst.

1. The CoA as a Legal and Quality Document

A Certificate of Analysis (CoA) is not a marketing flyer. It is a formal quality document that, in regulated industries, carries legal weight. In the unregulated gray-market peptide trade, however, CoAs are routinely fabricated, cherry-picked, or method-obscured to present a false picture of quality.

This guide walks through the forensic examination of a peptide CoA, from document-level authenticity to data-level consistency.

2. Document-Level Red Flags

2.1 Laboratory Identity and Accreditation

A legitimate CoA is issued by a laboratory with:

• A verifiable physical address (not a PO box or virtual office)
• Relevant accreditations (ISO 17025, CLIA, or state laboratory licensing)
• Named personnel (lab director, analyst) with verifiable credentials

Forgery indicators:

• Generic email addresses (Gmail, Yahoo, ProtonMail) instead of lab domain emails
• No accreditation numbers, or accreditation numbers that cannot be verified on the accrediting body’s website
• A “lab director” whose name does not appear in any professional registry or publication
• Laboratory names that are near-matches for well-known accredited labs (e.g., “Vanguard Labs” vs. “Vanguard Laboratory”)

2.2 Document Formatting and Metadata

Modern laboratory information management systems (LIMS) generate CoAs with consistent formatting, sequential document numbers, and embedded metadata. Forged CoAs often show:

• Inconsistent fonts or formatting within the same document
• Document numbers that don’t follow a logical sequence
• PDF metadata showing creation in Canva, Photoshop, or a generic PDF printer rather than a LIMS system
• Results that are suspiciously round (99.0%, 99.5%, 99.9%) across multiple analytes — real analytical data has natural variation

2.3 Batch and Lot Traceability

Every CoA should reference a specific batch or lot number that matches:

• The label on the vial or container
• The manufacturing record (if available)
• Any shipping documentation

Forgery indicator: The same CoA (same lot number, same results) appears for material purchased from multiple different suppliers, or for multiple shipments over months with no lot change.

3. Data-Level Consistency Checks

3.1 The Purity-Content Paradox

A CoA that reports 99.5% purity but does not report peptide content, water content, or counterion content is concealing information. The relationship is:

Peptide Content = Purity × (1 − Water% − Counterion% − Residual Solvent%)

If purity is 99.5% but water is 8% and acetate is 12%, the true peptide content is approximately 80.4%. A CoA that only reports the 99.5% purity figure is technically truthful but materially misleading.

3.2 HPLC Method Plausibility

A CoA should disclose:

• Column type (C18, C4, size exclusion)
• Mobile phase composition
• Gradient profile
• Detection wavelength
• Injection volume and sample concentration

Forgery indicator: A CoA that reports purity without any method details. Without method disclosure, you cannot assess whether the method is capable of resolving known impurities. A 10-minute gradient on a C18 column will not resolve peptide impurities that require a 45-minute gradient.

3.3 Mass Spectrometry Consistency

If a CoA includes mass spectrometry results, check:

• Does the reported mass match the theoretical mass of the declared peptide?
• Is the mass reported as monoisotopic or average? (These differ by 1–4 Da for peptides >2 kDa)
• Is the instrument specified? (TOF, Orbitrap, single quadrupole — each has different resolution and accuracy)

Forgery indicator: A reported mass that is exactly the theoretical average mass to two decimal places, with no mention of instrument tolerance. Real MS data includes a measured value, a theoretical value, and a delta (ppm or Da).

4. The Verification Protocol

When evaluating a supplier’s CoA, follow this protocol:

1. Verify the laboratory: Search for the lab name, address, and accreditation. Call the lab directly (using a phone number from their website, not the CoA) to confirm they issued the document.
2. Request raw data: Ask for the original chromatograms, mass spectra, and instrument log files. A legitimate lab will provide these on request. A forger will refuse or provide image files that cannot be analyzed.
3. Cross-check method: Compare the reported method against published pharmacopeial methods or peer-reviewed methods for the same peptide.
4. Independent retest: Send a sample from the same lot to an independent laboratory. This is the definitive verification step.

5. The Cost of Failing to Verify

The financial and legal consequences of accepting a fake CoA are significant:

• Product liability: If a compounded product harms a patient and the active ingredient was misidentified, the compounding pharmacy and distributor face liability.
• Regulatory action: FDA and state boards of pharmacy have increased enforcement against misbranded peptide products.
• Reputational damage: A single incident of supplying misidentified peptide can destroy a business’s reputation in this small, networked industry.

Independent testing costs $150–$500 per batch. The cost of not testing is potentially existential.

6. Conclusion

A CoA is only as credible as the laboratory behind it and the data within it. Forensic examination — document verification, data consistency checking, and independent retesting — is the only reliable defense against the pervasive fraud in the gray-market peptide supply chain. In this market, trust is not a strategy. Verification is.